Chester County News and Community Website
MALVERN, PA — CubeSmart (NYSE: CUBE), the third-largest owner and operator of self-storage properties in the United States, has been recognized as one of America’s Best Employers of 2021 by …
Read More
DEVON, PA — Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE) announced that Company management will participate in the 33rd Annual ROTH Conference, which will be held virtually on March 15-17, 2021.
Read More
KENNETT SQUARE, PA — Genesis Healthcare, Inc. (NYSE:GEN) this week announced a three-part strategic restructuring plan to strengthen the Company’s liquidity position and capital structure as it charts a path …
Read More
WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, announced that Ted White, Verrica President and CEO, will …
Read More
MALVERN, PA — Baudax Bio, Inc. (Nasdaq: BXRX) announced that Gerri Henwood, President and Chief Executive Officer, will give a corporate presentation at the H.C. Wainwright Global Life Sciences Conference, …
Read More
MALVERN, PA — Recro Pharma, Inc. (NASDAQ: REPH) announced that its chief executive officer, David Enloe, will deliver a corporate presentation as part of the H.C. Wainwright Global Life Science …
Read More
CHESTERBROOK, PA — Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, announced that management …
Read More
MALVERN, PA — PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiopulmonary diseases, announced that the company will be …
Read More
PAOLI, PA — Malvern Bancorp, Inc. (NASDAQ: MLVF), the parent company of Malvern Bank, National Association, announced that it received a notification letter on February 23, 2021 from The Nasdaq …
Read More MALVERN, PA — PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiopulmonary diseases, announced that it will host a …
Read More